facebook_pixel
Equity Strategy 24 September 2014
BLUE PHOENIX FINANCIALS PREMIUM CONTENT Not a member? Join Now!
Ayala Land. Buy. Plans 75B Peso Investment In Pampanga Province

Ayala Land. Buy. Plans 75B Peso Investment In Pampanga Province

* Ayala Land, Inc. operates as real estate company primarily in the Philippines. The company operates in Shopping Centers, Corporate Business, Residential Development, Strategic Landbank Management and Visayas-Mindanao, Construction, Hotels and Resorts, Property Management, and Others segments. The Residential developments segment is engaged in the sale of residential lots and units, housing units and lots, and […]

FIND OUT MORE

Equity Strategy 19 September 2014
BLUE PHOENIX FINANCIALS PREMIUM CONTENT Not a member? Join Now!
Facebook: Take Partial Profit Of 40.79%

Facebook: Take Partial Profit Of 40.79%

* As early as June 12, 2013 we advised to Buy Facebook Between $24 and $25: http://www.bluephoenixfinancials.com/equity-strategies/facebook-uptrend-starting-profit-potential-16-70/ * On 13 June 2013, Facebook traded as low as $23.26 * On 1 April 2014 we advised to Buy Facebook between $60 and $65: http://www.bluephoenixfinancials.com/equity-strategies/facebook-add-long-positions/ * NOTE: On 1 April 2014 we advised Investors who had the resources to […]

FIND OUT MORE

FX Strategy 19 September 2014
BLUE PHOENIX FINANCIALS PREMIUM CONTENT Not a member? Join Now!
USD/JPY: +16.72%. Take Profit

USD/JPY: +16.72%. Take Profit

* On 5 Mar 2014, we advised to Buy USD/JPY between Y102.00 and Y102.50. Target: Y108.00: http://www.bluephoenixfinancials.com/foreign-exchange-strategies/usdjpy-buy-uptrend-starting/ * On 14 Mar 2014, USD/JPY traded as low as Y101.21 * On 21 April 2014, we advised to Add to USD/JPY Long Positions between Y102.50 and Y102.80: http://www.bluephoenixfinancials.com/foreign-exchange-strategies/usdjpy-add-long-positions-japan-trade-deficit-widens/ * On 21 May USD/JPY traded as low as […]

FIND OUT MORE

Equity Strategy 18 September 2014
BLUE PHOENIX FINANCIALS PREMIUM CONTENT Not a member? Join Now!
AstraZeneca: Buy. Profit From Blockbuster Colorectal Cancer Drug

AstraZeneca: Buy. Profit From Blockbuster Colorectal Cancer Drug

* AstraZeneca PLC is engaged in the discovery, development, and commercialization of medicines for cardiovascular and metabolic disease; oncology; respiratory, inflammation, and autoimmunity; and infection, neuroscience, and gastrointestinal disease areas worldwide. Its principal products include Crestor for the treatment of dyslipidaemia and hypercholesterolemia; Seloken/Toprol-XL for control of hypertension and for use in heart failure and […]

FIND OUT MORE